Case report: Medical cannabis—warfarin drug-drug interaction

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2522-5782

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Case report: Medical cannabis—warfarin drug-drug interaction ; volume:4 ; number:1 ; day:10 ; month:1 ; year:2022 ; pages:1-6 ; date:12.2022
Journal of cannabis research ; 4, Heft 1 (10.1.2022), 1-6, 12.2022

Creator: Thomas, Tyan F.
Metaxas, Evdokia S.
Nguyen, Thu
Bennett, Whitni
Skiendzielewski, Kathryn V.
Quinn, Diane H.
Scaletta, Alice L.

Contributor: SpringerLink (Online service)

DOI: 10.1186/s42238-021-00112-x

URN: urn:nbn:de:101:1-2022042500563690696859

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:20 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Thomas, Tyan F.
Metaxas, Evdokia S.
Nguyen, Thu
Bennett, Whitni
Skiendzielewski, Kathryn V.
Quinn, Diane H.
Scaletta, Alice L.
SpringerLink (Online service)

Other Objects (12)

Lurasidone drug-drug interaction studies: a comprehensive review

Evaluating drug-drug interaction information in NDF-RT and DrugBank

Impact of Intracellular Concentrations on Metabolic Drug-Drug Interaction Studies

Evaluation of a drug-drug interaction: fax alert intervention program

Learning self-supervised molecular representations for drug–drug interaction prediction

On the robustness of generalization of drug–drug interaction models

Drug–drug interactions between sucroferric oxyhydroxide and losartan, furosemide, omeprazole, digoxin and warfarin in healthy subjects

Drug-drug interactions and risk of bleeding among inpatients on warfarin therapy: a prospective observational study

Drug–Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies

DDIGIP: predicting drug-drug interactions based on Gaussian interaction profile kernels

Targeting continuity of care and polypharmacy to reduce drug–drug interaction

Target mediated drug disposition with drug–drug interaction, Part II: competitive and uncompetitive cases

Lurasidone drug-drug interaction studies: a comprehensive review

Evaluating drug-drug interaction information in NDF-RT and DrugBank

Impact of Intracellular Concentrations on Metabolic Drug-Drug Interaction Studies

Evaluation of a drug-drug interaction: fax alert intervention program

Learning self-supervised molecular representations for drug–drug interaction prediction

On the robustness of generalization of drug–drug interaction models

Drug–drug interactions between sucroferric oxyhydroxide and losartan, furosemide, omeprazole, digoxin and warfarin in healthy subjects

Drug-drug interactions and risk of bleeding among inpatients on warfarin therapy: a prospective observational study

Drug–Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies

DDIGIP: predicting drug-drug interactions based on Gaussian interaction profile kernels

Targeting continuity of care and polypharmacy to reduce drug–drug interaction

Target mediated drug disposition with drug–drug interaction, Part II: competitive and uncompetitive cases

Lurasidone drug-drug interaction studies: a comprehensive review

Evaluating drug-drug interaction information in NDF-RT and DrugBank

Impact of Intracellular Concentrations on Metabolic Drug-Drug Interaction Studies

Evaluation of a drug-drug interaction: fax alert intervention program

Learning self-supervised molecular representations for drug–drug interaction prediction

On the robustness of generalization of drug–drug interaction models

Drug–drug interactions between sucroferric oxyhydroxide and losartan, furosemide, omeprazole, digoxin and warfarin in healthy subjects

Drug-drug interactions and risk of bleeding among inpatients on warfarin therapy: a prospective observational study

Drug–Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies

DDIGIP: predicting drug-drug interactions based on Gaussian interaction profile kernels

Targeting continuity of care and polypharmacy to reduce drug–drug interaction

Target mediated drug disposition with drug–drug interaction, Part II: competitive and uncompetitive cases

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Case report: Medical cannabis—warfarin drug-drug interaction

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Lurasidone drug-drug interaction studies: a comprehensive review

Evaluating drug-drug interaction information in NDF-RT and DrugBank

Impact of Intracellular Concentrations on Metabolic Drug-Drug Interaction Studies

Evaluation of a drug-drug interaction: fax alert intervention program

Learning self-supervised molecular representations for drug–drug interaction prediction

On the robustness of generalization of drug–drug interaction models

Drug–drug interactions between sucroferric oxyhydroxide and losartan, furosemide, omeprazole, digoxin and warfarin in healthy subjects

Drug-drug interactions and risk of bleeding among inpatients on warfarin therapy: a prospective observational study

Drug–Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies

DDIGIP: predicting drug-drug interactions based on Gaussian interaction profile kernels

Targeting continuity of care and polypharmacy to reduce drug–drug interaction

Target mediated drug disposition with drug–drug interaction, Part II: competitive and uncompetitive cases

Lurasidone drug-drug interaction studies: a comprehensive review

Evaluating drug-drug interaction information in NDF-RT and DrugBank

Impact of Intracellular Concentrations on Metabolic Drug-Drug Interaction Studies

Evaluation of a drug-drug interaction: fax alert intervention program

Learning self-supervised molecular representations for drug–drug interaction prediction

On the robustness of generalization of drug–drug interaction models

Drug–drug interactions between sucroferric oxyhydroxide and losartan, furosemide, omeprazole, digoxin and warfarin in healthy subjects

Drug-drug interactions and risk of bleeding among inpatients on warfarin therapy: a prospective observational study

Drug–Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies

DDIGIP: predicting drug-drug interactions based on Gaussian interaction profile kernels

Targeting continuity of care and polypharmacy to reduce drug–drug interaction

Target mediated drug disposition with drug–drug interaction, Part II: competitive and uncompetitive cases

Lurasidone drug-drug interaction studies: a comprehensive review

Evaluating drug-drug interaction information in NDF-RT and DrugBank

Impact of Intracellular Concentrations on Metabolic Drug-Drug Interaction Studies

Evaluation of a drug-drug interaction: fax alert intervention program

Learning self-supervised molecular representations for drug–drug interaction prediction

On the robustness of generalization of drug–drug interaction models

Drug–drug interactions between sucroferric oxyhydroxide and losartan, furosemide, omeprazole, digoxin and warfarin in healthy subjects

Drug-drug interactions and risk of bleeding among inpatients on warfarin therapy: a prospective observational study

Drug–Drug Interaction Potential of Darolutamide: In Vitro and Clinical Studies

DDIGIP: predicting drug-drug interactions based on Gaussian interaction profile kernels

Targeting continuity of care and polypharmacy to reduce drug–drug interaction

Target mediated drug disposition with drug–drug interaction, Part II: competitive and uncompetitive cases

Related objects

Reset password